Canadian 3D bioprinting company Aspect Biosystems has launched a new grant program whereby the selected applicants will be supplied with the company’s proprietary RX1 bioprinters. The developer of the Lab-on-a-Printer™ specializes in forming functional tissues by harnessing the power of microfluidics. The company’s ultimate aim is to use bioprinted therapeutics to heal musculoskeletal and metabolic […]
from 3D Printing Industry https://bit.ly/2RALUpS